Patient‐Reported Outcomes and Acceptability of a Microbiome‐Targeting Dermocosmetic Cream Used as Adjunct to Acne Treatment in Japanese Women: A Real‐World Pilot Study
Dermatologic Therapy · 2026-01 · 2026 (1)
DOI: 10.1155/dth/1437881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 22.07.2026. Verfasst von Atsuyuki Igarashi und 8 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acne is a common skin disease in Japanese women that is associated with a marked negative impact on quality of life. Increasing evidence from acne studies indicates that good skincare with over‐the‐counter (OTC) products with both cosmetic and therapeutic actions (dermocosmetics) may result in superior outcomes compared to medical therapy alone.
Methods
Real‐world, pilot observational study evaluating the adjunctive twice‐daily use of a dermocosmetic cream (niacinamide, panthenol, and pre‐ and postbiotic complex) in adult Japanese women receiving prescription acne treatment. Patient‐reported outcomes (PROs), acceptability, and safety were assessed at baseline, Week 2, and Week 4.
Results
A total of 40 women participated with a mean age of 24.4 years. All patients used topical anti‐acne treatment with 29 using topical antibiotics, 13 using benzoyl peroxide, 8 using topical retinoids, and 9 using combination drugs. There was a significant reduction in the number of noninflammatory acne lesions, and patients reported high satisfaction. In addition, the mean Cardiff Acne Disability Index total score was improved by Week 4. The dermocosmetic cream demonstrated good safety, with just one patient reporting itch as an adverse event that did not require study discontinuation.
Conclusions
In this real‐world pilot study, adjunctive use of a dermocosmetic cream was well tolerated and associated with improvements in PROs and quality of life. These preliminary findings support further evaluation in controlled studies. The absence of a control group, the heterogeneity of concomitant prescription treatments, and the short study duration should be considered when interpreting these results.
Zitieren
APA
Igarashi, A., Abe, M., Gunji, Y., Nemoto, O., Kawamura, K., Kerob, D., Yokozeki, M., Saito, A., & Ookawara, A. (2026). Patient‐Reported Outcomes and Acceptability of a Microbiome‐Targeting Dermocosmetic Cream Used as Adjunct to Acne Treatment in Japanese Women: A Real‐World Pilot Study. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/1437881
Vancouver
Igarashi A, Abe M, Gunji Y, Nemoto O, Kawamura K, Kerob D, et al. Patient‐Reported Outcomes and Acceptability of a Microbiome‐Targeting Dermocosmetic Cream Used as Adjunct to Acne Treatment in Japanese Women: A Real‐World Pilot Study. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/1437881
BibTeX
@article{Igarashi2026,
author = {Igarashi, Atsuyuki and Abe, Masatoshi and Gunji, Yurie and Nemoto, Osamu and Kawamura, Kuniko and Kerob, Delphine and Yokozeki, Mayumi and Saito, Atsushi and Ookawara, Akira},
title = {Patient‐Reported Outcomes and Acceptability of a Microbiome‐Targeting Dermocosmetic Cream Used as Adjunct to Acne Treatment in Japanese Women: A Real‐World Pilot Study},
journal = {Dermatologic Therapy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/dth/1437881}
}
EUVIMED